openPR Logo
Press release

Angiopoietin (ANG) Inhibitors Therapeutics Clinical Trials & Results | Regeneron Pharmaceuticals, Inc., Roche, Eli Lilly and Company, Boehringer Ingelheim

06-12-2019 12:13 PM CET | Health & Medicine

Press release from: Pharma Proff

Angiopoietin (ANG) receptor plays a crucial role in regulation of vascular permeability and pathological vascular remodelling during tumour angiogenesis, metastasis and inflammation. Thus, it has emerged as a new clinical approach for the development of therapeutics which treat cancer and ophthalmological diseases.

Download the sample report @ https://www.pharmaproff.com/request-sample/1173

The exclusive function of these receptors in vascular stabilization also makes it an attractive target in organ transplantation, sepsis, vascular complications of diabetes and atherosclerosis. There are various types of angiopoietins identified which includes ANG-1, ANG-2, ANG-3 and ANG-4. ANG-2 is the most commonly targeted receptor for the treatment of various diseases and demonstrated as potential therapeutics for anti-angiogenesis treatment for patients suffering from cancer.

Get the detailed analysis @ https://www.pharmaproff.com/report/ang-inhibitors-therapeutics

Company like Regeneron Pharmaceuticals Inc. is developing a combination of nesvacumab and aflibercept which acts as ANG-2 inhibitor and vascular endothelial growth factor A inhibitor, respectively for the treatment of retinal diseases (wet age-related macular degeneration and diabetic macular oedema). F. Hoffmann-La Roche Ltd., Eli Lilly and Company, and Boehringer Ingelheim International GmbH are some other key players having extensive pipeline of angiopoietin inhibitors.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1173

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licencing, grants, technology and others.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Angiopoietin (ANG) Inhibitors Therapeutics Clinical Trials & Results | Regeneron Pharmaceuticals, Inc., Roche, Eli Lilly and Company, Boehringer Ingelheim here

News-ID: 1772728 • Views:

More Releases from Pharma Proff

Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates. IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developments
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates. Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Pate …
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome. Download the sample report at: https://www.pharmaproff.com/request-sample/1189 Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant Growth due to Increasing Strategic Developments in the Coming Years | Top Players are Orphazyme A/S, IntraBio Ltd., CTD Holdings, Inc., Mallinckrodt Pharmaceuticals, SOM Biotec
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances

All 5 Releases


More Releases for ANG

A Cry In The Dark - New Book By Stroke Survivor Terence Ang
Stroke survivor Terence Ang is pleased to announce the release of his new book, A Cry In The Dark A Stroke Survivor's Story of Hope and Recovery. Ang will also be sharing his experiences while speaking at the 14th World Stroke Congress 2022 in Singapore from October 26 to 29 at Suntec Singapore Convention & Exhibition Centre. "Given a choice, I would have dressed for the occasion. I dressed for
Mandelic Acid Market Growth Opportunities During 2022-2028 | Zhongke Hua Ang, Ru …
Dark spots, wrinkles, dullness and acne are skin care problems that many are trying to overcome. Fortunately, many over-the-counter (OTC) products contain ingredients that address these particular concerns while improving the overall appearance of the skin. Mandelic acid is one of these beneficial ingredients. There is not much research on this alpha hydroxy acid (AHA), but it is considered to be skin-friendly and may help with the effects of acne, skin
Angiopoietin (ANG) Inhibitors Therapeutics - Pipeline Analysis 2019
Angiopoietin (ANG) receptor plays a crucial role in regulation of vascular permeability and pathological vascular remodelling during tumour angiogenesis, metastasis and inflammation. Thus, it has emerged as a new clinical approach for the development of therapeutics which treat cancer and ophthalmological diseases. Download the sample report @ https://www.pharmaproff.com/request-sample/1173 The exclusive function of these receptors in vascular stabilization also makes it an attractive target in organ transplantation, sepsis, vascular complications of diabetes
Global Conventional Lathe Market Forecast 2018-2025 Accuway Machinery, ANG Inter …
Recently added detailed market study "Global Conventional Lathe Market" examines the performance of the Conventional Lathe market 2018. It encloses an in-depth Research of the Conventional Lathe market state and the competitive landscape globally. This report analyzes the potential of Conventional Lathe market in the present and the future prospects from various angles in detail. The Global Conventional Lathe Market 2018 report includes Conventional Lathe market Revenue, market Share, Conventional Lathe
Global Drilling And Milling Machines Market Forecast 2018-2025 Bottero, ANG Inte …
Recently added detailed market study "Global Drilling And Milling Machines Market" examines the performance of the Drilling And Milling Machines market 2018. It encloses an in-depth Research of the Drilling And Milling Machines market state and the competitive landscape globally. This report analyzes the potential of Drilling And Milling Machines market in the present and the future prospects from various angles in detail. The Global Drilling And Milling Machines Market 2018
Nov 1, 2017: Drilling and Milling Machines Market Forecast 2023 Kira America, AN …
A market study ” Global Drilling and Milling Machines Market Forecast ” examines the performance of the Drilling and Milling Machines market Size 2017. It encloses an in-depth Research of the Drilling and Milling Machines market state and the competitive landscape globally. This report analyzes the potential of Drilling and Milling Machines market in the present and the future prospects from various angles in detail. Get Free Sample Of Report: https://goo.gl/SuSJAV The